Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia. (2019)
Attributed to:
Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bone.2019.04.016
PubMed Identifier: 31028957
Publication URI: http://europepmc.org/abstract/MED/31028957
Type: Journal Article/Review
Volume: 124
Parent Publication: Bone
ISSN: 1873-2763